ANDA 202983

ANCHEN PHARMS

FDA Drug Application

Application #202983

Application Sponsors

ANDA 202983

ANCHEN PHARMS

Marketing Status

• Discontinued: 001
• Discontinued: 002

Application Products

001	TABLET, EXTENDED RELEASE;ORAL	0.1MG	0	CLONIDINE HYDROCHLORIDE	CLONIDINE HYDROCHLORIDE
002	TABLET, EXTENDED RELEASE;ORAL	0.2MG	0	CLONIDINE HYDROCHLORIDE	CLONIDINE HYDROCHLORIDE

FDA Submissions

UNKNOWN;

ORIG

1

AP

2014-04-02

Submissions Property Types

ORIG

1

Null

19

CDER Filings

ANCHEN PHARMS

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202983
            [companyName] => ANCHEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"CLONIDINE HYDROCHLORIDE","activeIngredients":"CLONIDINE HYDROCHLORIDE","strength":"0.1MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"CLONIDINE HYDROCHLORIDE","activeIngredients":"CLONIDINE HYDROCHLORIDE","strength":"0.2MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/02\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2014-04-02
        )

)